Annual Interest Expense
N/A
December 1, 2024
Summary
- NBIX annual interest expense is not available.
Performance
NBIX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
December 1, 2024
Summary
- NBIX quarterly interest expense is not available.
Performance
NBIX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
December 1, 2024
Summary
- NBIX TTM interest expense is not available.
Performance
NBIX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
NBIX Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NBIX Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Neurocrine Biosciences Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $49.70 M(-44.7%) | $139.50 M(+55.3%) |
| Mar 2024 | - | $89.80 M(>+9900.0%) | $89.80 M(+2541.2%) |
| Dec 2023 | $4.60 M(-35.2%) | - | - |
| Jun 2023 | - | $0.00(-100.0%) | $3.40 M(-39.3%) |
| Mar 2023 | - | $1.10 M(0.0%) | $5.60 M(-21.1%) |
| Dec 2022 | $7.10 M(-72.5%) | $1.10 M(-8.3%) | $7.10 M(-43.7%) |
| Sep 2022 | - | $1.20 M(-45.5%) | $12.60 M(-30.0%) |
| Jun 2022 | - | $2.20 M(-15.4%) | $18.00 M(-18.2%) |
| Mar 2022 | - | $2.60 M(-60.6%) | $22.00 M(-14.7%) |
| Dec 2021 | $25.80 M(-21.3%) | $6.60 M(0.0%) | $25.80 M(-4.4%) |
| Sep 2021 | - | $6.60 M(+6.5%) | $27.00 M(-6.6%) |
| Jun 2021 | - | $6.20 M(-3.1%) | $28.90 M(-6.8%) |
| Mar 2021 | - | $6.40 M(-17.9%) | $31.00 M(-5.5%) |
| Dec 2020 | $32.80 M(+2.5%) | $7.80 M(-8.2%) | $32.80 M(-1.2%) |
| Sep 2020 | - | $8.50 M(+2.4%) | $33.20 M(+1.5%) |
| Jun 2020 | - | $8.30 M(+1.2%) | $32.70 M(+1.2%) |
| Mar 2020 | - | $8.20 M(0.0%) | $32.30 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $32.00 M(+4.9%) | $8.20 M(+2.5%) | $32.00 M(+1.5%) |
| Sep 2019 | - | $8.00 M(+1.3%) | $31.53 M(+1.1%) |
| Jun 2019 | - | $7.90 M(0.0%) | $31.20 M(+1.0%) |
| Mar 2019 | - | $7.90 M(+2.2%) | $30.90 M(+1.3%) |
| Dec 2018 | $30.50 M(+56.2%) | $7.73 M(+0.8%) | $30.50 M(+1.0%) |
| Sep 2018 | - | $7.67 M(+1.1%) | $30.19 M(+1.1%) |
| Jun 2018 | - | $7.59 M(+1.2%) | $29.85 M(+10.4%) |
| Mar 2018 | - | $7.50 M(+1.1%) | $27.03 M(+38.4%) |
| Dec 2017 | $19.52 M(>+9900.0%) | $7.42 M(+1.1%) | $19.52 M(+61.3%) |
| Sep 2017 | - | $7.34 M(+53.9%) | $12.10 M(+153.9%) |
| Jun 2017 | - | $4.77 M(>+9900.0%) | $4.77 M(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00 | $0.00 |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Dec 2008 | $7.03 M | - | - |
FAQ
- What is the all time high annual interest expense for Neurocrine Biosciences?
- What is the all time high quarterly interest expense for Neurocrine Biosciences?
- What is the all time high TTM interest expense for Neurocrine Biosciences?
What is the all time high annual interest expense for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual interest expense is $32.80 M
What is the all time high quarterly interest expense for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly interest expense is $89.80 M
What is the all time high TTM interest expense for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM interest expense is $139.50 M